Gene · 406901
Papers3,765
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 3,765
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lung Cancer in the Course of COPD-Emerging Problems Today. | Cancers (Basel) | 2022 | 35954482 | PubTator, text mining | PubMed |
| Regulatory Roles of Noncoding RNAs in the Progression of Gastrointestinal Cancers and Health Disparities. | Cells | 2022 | 35954293 | PubTator, text mining | PubMed |
| Knockdown of circ_0002194 protects against oxidized low-density lipoprotein-induced cell damage via the regulation of the miR-637/PACS2 axis in human vascular endothelial cells. | Interact Cardiovasc Thorac Surg | 2022 | 35951762 | PubTator, text mining | PubMed |
| Long noncoding RNAs in mesenchymal stromal/stem cells osteogenic differentiation: Implications in osteoarthritis pathogenesis. | World J Stem Cells | 2022 | 35949395 | PubTator, text mining | PubMed |
| Role of m6A writers, erasers and readers in cancer. | Exp Hematol Oncol | 2022 | 35945641 | PubTator, text mining | PubMed |
| Nrf2 signaling activation by a small molecule activator compound 16 inhibits hydrogen peroxide-induced oxidative injury and death in osteoblasts. | Cell Death Discov | 2022 | 35941127 | PubTator, text mining | PubMed |
| The Key Role of microRNAs in Initiation and Progression of Hepatocellular Carcinoma. | Front Oncol | 2022 | 35924150 | PubTator, text mining | PubMed |
| N6-Methyladenosine Reader YTHDF2 Enhances Non-Small-Cell Lung Cancer Cell Proliferation and Metastasis through Mediating circ_SFMBT2 Degradation. | Contrast Media Mol Imaging | 2022 | 35924072 | PubTator, text mining | PubMed |
| Transcriptome Analysis Reveals Hub Genes Regulating Autophagy in Patients With Severe COVID-19. | Front Genet | 2022 | 35923698 | PubTator, text mining | PubMed |
| Beta-Secretase-1 Antisense RNA Is Associated with Vascular Ageing and Atherosclerotic Cardiovascular Disease. | Thromb Haemost | 2022 | 35915966 | PubTator, text mining | PubMed |
| Analysis of Competitive Endogenous Mechanism and Survival Prognosis of Serum Exosomes in Ovarian Cancer Patients Based on Sequencing Technology and Bioinformatics. | Front Genet | 2022 | 35910206 | PubTator, text mining | PubMed |
| Mitochondrial Epigenetics Regulating Inflammation in Cancer and Aging. | Front Cell Dev Biol | 2022 | 35903542 | PubTator, text mining | PubMed |
| m6A methyltransferase METTL3-induced lncRNA SNHG17 promotes lung adenocarcinoma gefitinib resistance by epigenetically repressing LATS2 expression. | Cell Death Dis | 2022 | 35902569 | PubTator, text mining | PubMed |
| miR-3156-5p is downregulated in serum of MEN1 patients and regulates expression of MORF4L2. | Endocr Relat Cancer | 2022 | 35900839 | PubTator, text mining | PubMed |
| The Exosome Journey: From Biogenesis to Regulation and Function in Cancers. | J Oncol | 2022 | 35898929 | PubTator, text mining | PubMed |
| Promising Biomarkers in Head and Neck Cancer: The Most Clinically Important miRNAs. | Int J Mol Sci | 2022 | 35897831 | PubTator, text mining | PubMed |
| Deciphering the Molecular Mechanism of Incurable Muscle Disease by a Novel Method for the Interpretation of miRNA Dysregulation. | Noncoding RNA | 2022 | 35893231 | PubTator, text mining | PubMed |
| Epigenetic Peripheral Biomarkers for Early Diagnosis of Alzheimer's Disease. | Genes (Basel) | 2022 | 35893045 | PubTator, text mining | PubMed |
| MiRNAs and circRNAs for the Diagnosis of Anthracycline-Induced Cardiotoxicity in Breast Cancer Patients: A Narrative Review. | J Pers Med | 2022 | 35887556 | PubTator, text mining | PubMed |
| MicroRNAs as Innovative Biomarkers for Inflammatory Bowel Disease and Prediction of Colorectal Cancer. | Int J Mol Sci | 2022 | 35887337 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406901/papers?page=38